Role of stimulated intrarenal angiotensinogen in hypertension

Therapeutic Advances in Cardiovascular Disease

Volumn 9, Issue 4, 2015, Pages 181-190

  Satou, Ryousuke ^a   Shao, Weijian ^a   Navar, L Gabriel ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

angiotensin II; AT1 receptor; proximal tubule cells; sodium reabsorption

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; RENIN; SODIUM; ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GAMMA INTERFERON; INTERLEUKIN 6; JANUS KINASE; REACTIVE OXYGEN METABOLITE; STAT PROTEIN;

ANIMAL; HUMAN; HYPERTENSION; KIDNEY DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSPORT AT THE CELLULAR LEVEL; VASOCONSTRICTION; BLOOD PRESSURE REGULATION; BODY FLUID HOMEOSTASIS; CELL GROWTH; CELL MIGRATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ELECTROLYTE BALANCE; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLOMERULONEPHRITIS; HOMEOSTASIS; IMMUNOGLOBULIN A NEPHROPATHY; INTERNALIZATION; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; UPREGULATION;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; HYPERTENSION; KIDNEY DISEASES; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM; VASOCONSTRICTION;

EID: 84940831078     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944715585512     Document Type: Review

References (81)

1. Babu C. Kalaivani P. Ranju V. Sathiya S. Anbarasi C. Mahadevan M. et al. (2014) Venthamarai chooranam, a polyherbal Siddha medicine, alleviates hypertension via AT 1R and eNOS signaling pathway in 2K1C hypertensive rats. Exp Biol Med (Maywood) 239: 758–769.
2. Beevers D. Maheshwari M. Ryan P. Moss M. Harding L. (2008) Hypertension due to a renin-secreting juxtaglomerular cell tumor. Am J Hypertens 21: 1359–1361.
3. Bouby N. Hus-Citharel A. Marchetti J. Bankir L. Corvol P. Llorens-Cortes C. (1997) Expression of type 1 angiotensin II receptor subytpes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol 8: 1658–1667.
4. Brands M. Banes-Berceli A. Inscho E. Al Azawi H. Allen A. Labazi H. (2010) Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and Janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension 56: 879–884.
5. Brasier A. Li J. (1996) Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27: 465–475.
6. Bravo Y. Quiroz Y. Ferrebuz A. Vaziri N. Rodriguez-Iturbe B. (2007) Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension. Am J Physiol Renal Physiol 293: F616–F623.
7. Burns K. Inagami T. Harris R. (1993) Cloning of a rabbit kidney cortex at 1 angiotensin II receptor that is present in proximal tubule epithelium. Am J Physiol Renal Physiol 264: F645–F654.
8. Carey R. (2005) Update on the role of the AT 2 receptor. Curr Opin Nephrol Hypertens 14: 67–71.
9. Cervenka L. Horacek V. Vaneckova I. Hubacek J. Oliverio M. Coffman T. et al. (2002) Essential role of AT 1A receptor in the development of 2k1C hypertension. Hypertension 40: 735–741.
10. Cervenka L. Vaneckova I. Huskova Z. Vanourkova Z. Erbanova M. Thumova M. et al. (2008) Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. J Hypertens 26: 1379–1389.
11. Crowley S. Frey C. Gould S. Griffiths R. Ruiz P. Burchette J. et al. (2008) Stimulation of Lymphocyte Responses by Angiotensin Ii Promotes Kidney Injury in Hypertension. Am J Physiol Renal Physiol 295: F515–F524.
12. Crowley S. Gurley S. Herrera M. Ruiz P. Griffiths R. Kumar A. et al. (2006) Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985–17990.
13. Gonzalez-Villalobos R. Billet S. Kim C. Satou R. Fuchs S. Bernstein K. et al. (2011) Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion. J Am Soc Nephrol 22: 449–459.
14. Gonzalez-Villalobos R. Janjoulia T. Fletcher N. Giani J. Nguyen M. Riquier-Brison A. et al. (2013) The absence of intrarenal ACE protects against hypertension. J Clin Invest 123: 2011–2023.
15. Gonzalez-Villalobos R. Satou R. Seth D. Semprun-Prieto L. Katsurada A. Kobori H. et al. (2009) Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension 53: 351–355.
16. Gonzalez-Villalobos R. Seth D. Satou R. Horton H. Ohashi N. Miyata K. et al. (2008) Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol 295: F772–F779.
17. Guilluy C. Bregeon J. Toumaniantz G. Rolli-Derkinderen M. Retailleau K. Loufrani L. et al. (2010) The Rho exchange factor Arhgef 1 mediates the effects of angiotensin II on vascular Tone and blood pressure. Nat Med 16: 183–190.
18. Harrison-Bernard L. Navar L. Ho M. Vinson G. El-Dahr S. (1997) Immunohistochemical localization of Ang II at 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol Renal Physiol 273: F170–F177.
19. Harrison-Bernard L. Zhuo J. Kobori H. Ohishi M. Navar L. (2002) Intrarenal AT 1 receptor and ACE binding in angiotensin II-induced hypertensive rats. Am J Physiol Renal Physiol 282: F19–F25.
20. Higuchi S. Ohtsu H. Suzuki H. Shirai H. Frank G. Eguchi S. (2007) Angiotensin II signal transduction through the AT 1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 112: 417–428.
21. Ingert C. Grima M. Coquard C. Barthelmebs M. Imbs J. (2002) Effects of dietary salt changes on renal renin–angiotensin system in rats. Am J Physiol Renal Physiol 283: F995–F1002.
22. Jain S. Shah M. Li Y. Vinukonda G. Sehgal P. Kumar A. (2006) Upregulation of human angiotensinogen (AGT) gene transcription by interferon-gamma: involvement of the Stat 1-binding motif in the AGT promoter. Biochim Biophys Acta 1759: 340–347.
23. Kamiyama M. Zsombok A. Kobori H. (2012) Urinary angiotensinogen as a novel early biomarker of intrarenal renin–angiotensin system activation in experimental type 1 diabetes. J Pharmacol Sci 119: 314–323.
24. Kim S. Song S. Kim I. Yang J. Lee J. Kwak I. et al. (2012) Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract 97: 251–257.
25. Kobayashi S. Ishida A. Moriya H. Mori N. Fukuda T. Takamura T. (1999) Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic changes. J Lab Clin Med 133: 134–143.
26. Kobori H. Alper A. Jr Shenava R. Katsurada A. Saito T. Ohashi N. et al. (2009) Urinary angiotensinogen as a novel biomarker of the intrarenal renin–angiotensin system status in hypertensive patients. Hypertension 53: 344–350.
27. Kobori H. Harrison-Bernard L. Navar L. (2001) Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12: 431–439.
28. Kobori H. Harrison-Bernard L. Navar L. (2002) Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61: 579–585.
29. Kobori H. Nangaku M. Navar L. Nishiyama A. (2007 a) The intrarenal renin–angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251–287.
30. Kobori H. Nishiyama A. Abe Y. Navar L. (2003 a) Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592–597.
31. Kobori H. Nishiyama A. Harrison-Bernard L. Navar L. (2003 b) Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 41: 42–49.
32. Kobori H. Ozawa Y. Satou R. Katsurada A. Miyata K. Ohashi N. et al. (2007 b) Kidney-specific enhancement of Ang II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol 293: F938–F945.
33. Kobori H. Prieto-Carrasquero M. Ozawa Y. Navar L. (2004) AT 1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43: 1126–1132.
34. Lara L. McCormack M. Semprum-Prieto L. Shenouda S. Majid D. Kobori H. et al. (2012) AT 1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in Ang II-salt hypertension. Am J Physiol Renal Physiol 302: F85–F94.
35. Lee D. Sturgis L. Labazi H. Osborne J. Jr Fleming C. Pollock J. et al. (2006) Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 290: H935–H940.
36. Li J. Brasier A. (1996) Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p 65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10: 252–264.
37. Lo C. Chang S. Chenier I. Filep J. Ingelfinger J. Zhang S. et al. (2012) Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes 61: 2597–2608.
38. Matsusaka T. Niimura F. Pastan I. Shintani A. Nishiyama A. Ichikawa I. (2014) Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation. Kidney Int 85: 1068–1077.
39. Mehta P. Griendling K. (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82–C97.
40. Michel F. Norton G. Maseko M. Majane O. Sareli P. Woodiwiss A. (2014) Urinary angiotensinogen excretion is associated with blood pressure independent of the circulating renin–angiotensin system in a group of African ancestry. Hypertension 64: 149–156.
41. Milani C. Kobori H. Mullins J. Mitchell K. (2010) Enhanced urinary angiotensinogen excretion in Cyp 1a1-Ren2 transgenic rats with inducible Ang II-dependent malignant hypertension. Am J Med Sci 340: 389–394.
42. Mills K. Kobori H. Hamm L. Alper A. Khan I. Rahman M. et al. (2012) Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant 27: 3176–3181.
43. Miyata K. Satou R. Shao W. Prieto M. Urushihara M. Kobori H. et al. (2014) Rock/NF-kappaB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol 306: F608–F618.
44. Navar L. (2013) Translational studies on augmentation of intratubular renin–angiotensin system in hypertension. Kidney Int Suppl 3: 321–325.
45. Navar L. Harrison-Bernard L. (2000) Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension. Hypertens Res 23: 291–301.
46. Navar L. Harrison-Bernard L. Imig J. Cervenka L. Mitchell K. (2000) Renal responses to AT 1 receptor blockade. Am J Hypertens 13: 45S–54S.
47. Navar L. Harrison-Bernard L. Nishiyama A. Kobori H. (2002) Regulation of intrarenal angiotensin II in hypertension. Hypertension 39: 316–322.
48. Navar L. Harrison-Bernard L. Wang C. Cervenka L. Mitchell K. (1999) Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 10: S189–S195.
49. Navar L. Kobori H. Prieto M. Gonzalez-Villalobos R. (2011) Intratubular renin–angiotensin system in hypertension. Hypertension 57: 355–362.
50. Navar L. Prieto M. Satou R. Kobori H. (2011) Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 11: 180–186.
51. Navar L. Shao W. Satou R. Prieto M. Miyata K. Katsurada A. et al. (2014) Increased renal angiotensinogen expression in non-clipped kidneys of 2-kidney 1-clip hypertensive rats. AHA High Blood Pressure Research Conference, San Francisco, CA, 9–12 September 2014 (Hypertension 64: A 519).
52. Nishiyama A. Konishi Y. Ohashi N. Morikawa T. Urushihara M. Maeda I. et al. (2011) Urinary angiotensinogen reflects the activity of intrarenal renin–angiotensin system in patients with IGA nephropathy. Nephrol Dial Transplant 26: 170–177.
53. Ogawa S. Kobori H. Ohashi N. Urushihara M. Nishiyama A. Mori T. et al. (2009) Angiotensin II type 1 receptor blockers reduce urinary angiotensinogen excretion and the levels of urinary markers of oxidative stress and inflammation in patients with type 2 diabetic nephropathy. Biomark Insights 4: 97–102.
54. Ozawa Y. Kobori H. Suzaki Y. Navar L. (2007) Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 292: F330–F339.
55. Park S. Bivona B. Kobori H. Seth D. Chappell M. Lazartigues E. et al. (2010) Major role for ACE-independent intrarenal Ang II formation in type II diabetes. Am J Physiol Renal Physiol 298: F37–F48.
56. Pohl M. Kaminski H. Castrop H. Bader M. Himmerkus N. Bleich M. et al. (2010) Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 285: 41935–41946.
57. Prieto M. Gonzalez-Villalobos R. Botros F. Martin V. Pagan J. Sato R. et al. (2011) Reciprocal changes in renal ACE / Ang II and ACE 2/Ang 1–7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am J Physiol Renal Physiol 300: F749–F755.
58. Rands V. Seth D. Kobori H. Prieto M. (2012) Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. Gend Med 9: 207–218.
59. Recinos A. 3rd Lejeune W. Sun H. Lee C. Tieu B. Lu M. et al. (2007) Angiotensin II induces IL-6 expression and the Jak-Stat3 pathway in aortic adventitia of LDL receptor-deficient mice. Atherosclerosis 194: 125–133.
60. Ruiz-Ortega M. Ruperez M. Lorenzo O. Esteban V. Blanco J. Mezzano S. et al. (2002) Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl: S12–S22.
61. Sachetelli S. Liu Q. Zhang S. Liu F. Hsieh T. Brezniceanu M. et al. (2006) RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 69: 1016–1023.
62. Saha B. Jyothi Prasanna S. Chandrasekar B. Nandi D. (2010) Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50: 1–14.
63. Saito T. Urushihara M. Kotani Y. Kagami S. Kobori H. (2009) Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 338: 478–480.
64. Satou R. Gonzalez-Villalobos R. (2012) JAK-STAT and the renin–angiotensin system: the role of the JAK-STAT pathway in blood pressure and intrarenal renin–angiotensin system regulation. JAKSTAT 1: 250–256.
65. Satou R. Gonzalez-Villalobos R. Miyata K. Ohashi N. Katsurada A. Navar L. et al. (2008) Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol 295: F283–F289.
66. Satou R. Miyata K. Gonzalez-Villalobos R. Ingelfinger J. Navar L. Kobori H. (2012) Interferon-gamma biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J 26: 1821–1830.
67. Schunkert H. Ingelfinger J. Jacob H. Jackson B. Bouyounes B. Dzau V. (1992) Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol Heart Circ Physiol 263: E863–E869.
68. Shao W. Seth D. Navar L. (2009) Augmentation of endogenous intrarenal angiotensin II levels in Val 5-ANG II-infused rats. Am J Physiol Renal Physiol 296: F1067–F1071.
69. Shao W. Seth D. Navar L. (2010) Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val 5-angiotensin II-infused rats. Hypertension 56: 378–383.
70. Shao W. Seth D. Prieto M. Kobori H. Navar L. (2013) Activation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in rats. Am J Physiol Renal Physiol 304: F505–F514.
71. Susic D. Frohlich E. Kobori H. Shao W. Seth D. Navar L. (2011) Salt-induced renal injury in SHRS is mediated by AT 1 receptor activation. J Hypertens 29: 716–723.
72. Touyz R. Berry C. (2002) Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001–1015.
73. Urushihara M. Kondo S. Kagami S. Kobori H. (2010) Urinary angiotensinogen accurately reflects intrarenal renin–angiotensin system activity. Am J Nephrol 31: 318–325.
74. Ushio-Fukai M. Alexander R. Akers M. Lyons P. Lassegue B. Griendling K. (1999) angiotensin II receptor coupling to phospholipase D is mediated by the betagamma subunits of heterotrimeric G proteins in vascular smooth muscle cells. Mol Pharmacol 55: 142–149.
75. Von Thun A. Vari R. El-Dahr S. Navar L. (1994) Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol Renal Physiol 266: F120–F128.
76. Ying J. Stuart D. Hillas E. Gociman B. Ramkumar N. Lalouel J. et al. (2012) Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens 25: 684–689.
77. Zhang W. Wang W. Yu H. Zhang Y. Dai Y. Ning C. et al. (2012) Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension 59: 136–144.
78. Zhuo J. Imig J. Hammond T. Orengo S. Benes E. Navar L. (2002) Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 39: 116–121.
79. Zou L. Imig J.D. Hymel A. Navar L. (1998) Renal uptake of circulating angiotensin II in Val 5-angiotensin II infused rats is mediated by AT 1 receptor. Am J Hypertens 11: 570–578.
80. Zou L. Hymel A. Imig J. Navar L. (1996 a) Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension 27: 658–662.
81. Zou L. Imig J. Von Thun A. Hymel A. Ono H. Navar L. (1996 b) Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension 28: 669–677.